Burden of intracerebral haemorrhage in Europe : forecasting incidence and mortality between 2019 and 2050
© 2024 The Authors..
Background: Anticipating the burden of intracerebral haemorrhage is crucial for proactive management and building resilience against future health challenges. Prior forecasts are based on population demography and to a lesser extent epidemiological trends. This study aims to utilise selected modifiable risk factors and socio-demographic indicators to forecast the incidence and mortality of intracerebral haemorrhage in Europe between 2019 and 2050.
Methods: Three intracerebral haemorrhage risk factors identified in the Global Burden of Diseases, Injuries, and Risk Factors study (GBD 2019)-high systolic blood pressure, high fasting plasma glucose, and high body mass index-were utilised to predict the risk-attributable fractions between 2019 and 2050. Disease burden not attributable to these risk factors was then forecasted using time series models (autoregressive integrated moving average [ARIMA]), incorporating the Socio-demographic Index (SDI) as an external predictor. The optimal parameters of ARIMA models were selected for each age-sex-country group based on the Akaike Information Criterion (AIC). Different health scenarios were constructed by extending the past 85th and 15th percentiles of annualised rates of change in risk factors and SDI across all location-years, stratified by age and sex groups. A decomposition analysis was performed to assess the relative contributions of population size, age composition, and intracerebral haemorrhage risk on the projected changes.
Findings: Compared with observed figures in 2019, our analysis predicts an increase in the burden of intracerebral haemorrhage in Europe in 2050, with a marginal rise of 0.6% (95% uncertainty interval [UI], -7.4% to 9.6%) in incident cases and an 8.9% (-2.8% to 23.6%) increase in mortality, reaching 141.2 (120.6-166.5) thousand and 144.2 (122.9-172.2) thousand respectively. These projections may fluctuate depending on trajectories of the risk factors and SDI; worsened trends could result in increases of 16.7% (8.7%-25.3%) in incidence and 31.2% (17.7%-48%) in mortality, while better trajectories may lead to a 10% (16.4%-2.3%) decrease in intracerebral haemorrhage cases with stabilised mortality. Individuals aged ≥80 years are expected to contribute significantly to the burden, comprising 62.7% of the cases in 2050, up from 40% in 2019, and 72.5% of deaths, up from 50.5%. Country-wide variations were noted in the projected changes, with decreases in the standardised rates across all nations but varying crude rates. The largest relative reductions in counts for both incidence and mortality are expected in Latvia, Bulgaria, and Hungary-ranging from -38.2% to -32.4% and -37.3% to -30.2% respectively. In contrast, the greatest increases for both measures were forecasted in Ireland (45.7% and 74.4%), Luxembourg (45% and 70.7%), and Cyprus (44.5% and 74.2%). The modelled increase in the burden of intracerebral haemorrhage could largely be attributed to population ageing.
Interpretation: This study provides a comprehensive forecast of intracerebral haemorrhage in Europe until 2050, presenting different trajectories. The potential increase in the number of people experiencing and dying from intracerebral haemorrhage could have profound implications for both caregiving responsibilities and associated costs. However, forecasts were divergent between different scenarios and among EU countries, signalling the pivotal role of public health initiatives in steering the trajectories.
Funding: The European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 754517. The National Institute for Health and Care Research (NIHR) under its Programme Grants for Applied Research (NIHR202339).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
The Lancet regional health. Europe - 38(2024) vom: 12. Feb., Seite 100842 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wafa, Hatem A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Epidemiology |
|---|
| Anmerkungen: |
Date Revised 17.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.lanepe.2024.100842 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368525805 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368525805 | ||
| 003 | DE-627 | ||
| 005 | 20240217232425.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240216s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lanepe.2024.100842 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1297.xml |
| 035 | |a (DE-627)NLM368525805 | ||
| 035 | |a (NLM)38362494 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wafa, Hatem A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Burden of intracerebral haemorrhage in Europe |b forecasting incidence and mortality between 2019 and 2050 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. | ||
| 520 | |a Background: Anticipating the burden of intracerebral haemorrhage is crucial for proactive management and building resilience against future health challenges. Prior forecasts are based on population demography and to a lesser extent epidemiological trends. This study aims to utilise selected modifiable risk factors and socio-demographic indicators to forecast the incidence and mortality of intracerebral haemorrhage in Europe between 2019 and 2050 | ||
| 520 | |a Methods: Three intracerebral haemorrhage risk factors identified in the Global Burden of Diseases, Injuries, and Risk Factors study (GBD 2019)-high systolic blood pressure, high fasting plasma glucose, and high body mass index-were utilised to predict the risk-attributable fractions between 2019 and 2050. Disease burden not attributable to these risk factors was then forecasted using time series models (autoregressive integrated moving average [ARIMA]), incorporating the Socio-demographic Index (SDI) as an external predictor. The optimal parameters of ARIMA models were selected for each age-sex-country group based on the Akaike Information Criterion (AIC). Different health scenarios were constructed by extending the past 85th and 15th percentiles of annualised rates of change in risk factors and SDI across all location-years, stratified by age and sex groups. A decomposition analysis was performed to assess the relative contributions of population size, age composition, and intracerebral haemorrhage risk on the projected changes | ||
| 520 | |a Findings: Compared with observed figures in 2019, our analysis predicts an increase in the burden of intracerebral haemorrhage in Europe in 2050, with a marginal rise of 0.6% (95% uncertainty interval [UI], -7.4% to 9.6%) in incident cases and an 8.9% (-2.8% to 23.6%) increase in mortality, reaching 141.2 (120.6-166.5) thousand and 144.2 (122.9-172.2) thousand respectively. These projections may fluctuate depending on trajectories of the risk factors and SDI; worsened trends could result in increases of 16.7% (8.7%-25.3%) in incidence and 31.2% (17.7%-48%) in mortality, while better trajectories may lead to a 10% (16.4%-2.3%) decrease in intracerebral haemorrhage cases with stabilised mortality. Individuals aged ≥80 years are expected to contribute significantly to the burden, comprising 62.7% of the cases in 2050, up from 40% in 2019, and 72.5% of deaths, up from 50.5%. Country-wide variations were noted in the projected changes, with decreases in the standardised rates across all nations but varying crude rates. The largest relative reductions in counts for both incidence and mortality are expected in Latvia, Bulgaria, and Hungary-ranging from -38.2% to -32.4% and -37.3% to -30.2% respectively. In contrast, the greatest increases for both measures were forecasted in Ireland (45.7% and 74.4%), Luxembourg (45% and 70.7%), and Cyprus (44.5% and 74.2%). The modelled increase in the burden of intracerebral haemorrhage could largely be attributed to population ageing | ||
| 520 | |a Interpretation: This study provides a comprehensive forecast of intracerebral haemorrhage in Europe until 2050, presenting different trajectories. The potential increase in the number of people experiencing and dying from intracerebral haemorrhage could have profound implications for both caregiving responsibilities and associated costs. However, forecasts were divergent between different scenarios and among EU countries, signalling the pivotal role of public health initiatives in steering the trajectories | ||
| 520 | |a Funding: The European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 754517. The National Institute for Health and Care Research (NIHR) under its Programme Grants for Applied Research (NIHR202339) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Europe | |
| 650 | 4 | |a Future | |
| 650 | 4 | |a Intracerebral haemorrhage | |
| 650 | 4 | |a Stroke | |
| 700 | 1 | |a Marshall, Iain |e verfasserin |4 aut | |
| 700 | 1 | |a Wolfe, Charles D A |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Wanqing |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Catherine O |e verfasserin |4 aut | |
| 700 | 1 | |a Veltkamp, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yanzhong |e verfasserin |4 aut | |
| 700 | 0 | |a PRESTIGE-AF consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Veltkamp, Roland |e investigator |4 oth | |
| 700 | 1 | |a Harvey, Kirsten H |e investigator |4 oth | |
| 700 | 1 | |a Korompoki, Eleni |e investigator |4 oth | |
| 700 | 1 | |a D'Anna, Lucio |e investigator |4 oth | |
| 700 | 1 | |a Halse, Omid |e investigator |4 oth | |
| 700 | 1 | |a Harvey, Emily R |e investigator |4 oth | |
| 700 | 1 | |a Hügen, Klemens |e investigator |4 oth | |
| 700 | 1 | |a Malzahn, Uwe |e investigator |4 oth | |
| 700 | 1 | |a Ullmann, Sabine |e investigator |4 oth | |
| 700 | 1 | |a Schuhmann, Carolin |e investigator |4 oth | |
| 700 | 1 | |a Todd, Gabriele Putz |e investigator |4 oth | |
| 700 | 1 | |a Brinz, Hannes |e investigator |4 oth | |
| 700 | 1 | |a Fiessler, Cornelia |e investigator |4 oth | |
| 700 | 1 | |a Heuschmann, Peter U |e investigator |4 oth | |
| 700 | 1 | |a Haas, Kirsten |e investigator |4 oth | |
| 700 | 1 | |a Rücker, Viktoria |e investigator |4 oth | |
| 700 | 1 | |a Enzinger, Christian |e investigator |4 oth | |
| 700 | 1 | |a Ropele, Stefan |e investigator |4 oth | |
| 700 | 1 | |a Pinter, Daniela |e investigator |4 oth | |
| 700 | 1 | |a Haidegger, Melanie |e investigator |4 oth | |
| 700 | 1 | |a Gattringer, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Fandler-Höfler, Simon |e investigator |4 oth | |
| 700 | 1 | |a Wolfe, Charles DA |e investigator |4 oth | |
| 700 | 1 | |a Wang, Yanzhong |e investigator |4 oth | |
| 700 | 1 | |a Wafa, Hatem A |e investigator |4 oth | |
| 700 | 1 | |a Montaner, Joan |e investigator |4 oth | |
| 700 | 1 | |a Palà, Elena |e investigator |4 oth | |
| 700 | 1 | |a Penalba, Anna |e investigator |4 oth | |
| 700 | 1 | |a Vallverdu, Marcel Lamana |e investigator |4 oth | |
| 700 | 1 | |a Pilco, Daisy Guaman |e investigator |4 oth | |
| 700 | 1 | |a Debette, Stéphanie |e investigator |4 oth | |
| 700 | 1 | |a Sibon, Igor |e investigator |4 oth | |
| 700 | 1 | |a Renou, Pauline |e investigator |4 oth | |
| 700 | 1 | |a Lachaize, Morgane |e investigator |4 oth | |
| 700 | 1 | |a Milan, Léa |e investigator |4 oth | |
| 700 | 1 | |a Heyvang, Nathalie |e investigator |4 oth | |
| 700 | 1 | |a Ledure, Sylvain |e investigator |4 oth | |
| 700 | 1 | |a Michel, Pascale |e investigator |4 oth | |
| 700 | 1 | |a Conhoc, Johanna |e investigator |4 oth | |
| 700 | 1 | |a Donnadieu, Léa |e investigator |4 oth | |
| 700 | 1 | |a Hyves, Kelly |e investigator |4 oth | |
| 700 | 1 | |a Caso, Valeria |e investigator |4 oth | |
| 700 | 1 | |a Mosconi, Maria Giulia |e investigator |4 oth | |
| 700 | 1 | |a Graziani, Mara |e investigator |4 oth | |
| 700 | 1 | |a Cancelloni, Virginia |e investigator |4 oth | |
| 700 | 1 | |a Marchini, Laura |e investigator |4 oth | |
| 700 | 1 | |a Koehler, Bianca Emanuela |e investigator |4 oth | |
| 700 | 1 | |a Nielsen, Peter Brønnum |e investigator |4 oth | |
| 700 | 1 | |a Larsen, Torben Bjerregaard |e investigator |4 oth | |
| 700 | 1 | |a Lip, Gregory Yh |e investigator |4 oth | |
| 700 | 1 | |a Horstmann, Solveigh |e investigator |4 oth | |
| 700 | 1 | |a Purrucker, Jan |e investigator |4 oth | |
| 700 | 1 | |a Ringleb, Peter |e investigator |4 oth | |
| 700 | 1 | |a Haffa, Mariam |e investigator |4 oth | |
| 700 | 1 | |a Klein, Sabrina |e investigator |4 oth | |
| 700 | 1 | |a Taylor, Lenka |e investigator |4 oth | |
| 700 | 1 | |a Hoppe-Tichy, Torsten |e investigator |4 oth | |
| 700 | 1 | |a Haefeli, Walter E |e investigator |4 oth | |
| 700 | 1 | |a Seidling, Hanna M |e investigator |4 oth | |
| 700 | 1 | |a Burhenne, Jürgen |e investigator |4 oth | |
| 700 | 1 | |a Foerster, Kathrin I |e investigator |4 oth | |
| 700 | 1 | |a Wurmbach, Viktoria |e investigator |4 oth | |
| 700 | 1 | |a Marquart, Claudia |e investigator |4 oth | |
| 700 | 1 | |a Lane, Deirdre A |e investigator |4 oth | |
| 700 | 1 | |a Lip, Gregory Yh |e investigator |4 oth | |
| 700 | 1 | |a Ivany, Elena |e investigator |4 oth | |
| 700 | 1 | |a Lotto, Robyn |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet regional health. Europe |d 2021 |g 38(2024) vom: 12. Feb., Seite 100842 |w (DE-627)NLM323979734 |x 2666-7762 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g day:12 |g month:02 |g pages:100842 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lanepe.2024.100842 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2024 |b 12 |c 02 |h 100842 | ||